AIDS Nonprofit Says BMS Overcharged For Drugs
The complaint, filed last Wednesday in the U.S. District Court for the Central District of California, claims that Bristol-Myers failed to promptly lower drug prices for nonprofit and governmental medical providers as required by the new health care law, overcharging the AIDS Healthcare Foundation by more than $124,000.
The Patient Protection and Affordable...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login